- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.09. | AstraZeneca's Trixeo gets EU approval for asthma maintenance treatment | ||
| 23.09. | Engitix appoints Sonia Quaratino as EVP Chief Medical Officer | ||
| 22.09. | CSL Seqirus announces strengthened vaccine partnership with UK government | ||
| 22.09. | Galimedix establishes Alzheimer's Disease Scientific Advisory Board | ||
| 21.09. | The Emmes Group's Board of Directors has appointed Rama Kondru as CEO | ||
| 21.09. | Novartis' Cosentyx gets positive CHMP opinion for polymyalgia rheumatica | ||
| 18.09. | PMi Awards 2026 - the winners and highlights | ||
| 18.09. | Cancer researchers investigate why smouldering myeloma progresses | ||
| 18.09. | Quantitative Biosciences Institute Appoints Brad Schneider as COO | ||
| 17.09. | Pharma-Exclusive Webinar: Redefining Engagement in the AI Era | ||
| 17.09. | Frontera Global appoints Steph Wasek as General Manager and Mohammed Saleh Bham as Director of Growth | ||
| 17.09. | Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn | ||
| 16.09. | The Power of Plurality | ||
| 16.09. | Governor Josh Stein marks strengthening North Carolina-Ireland trade relationship at Uniphar facility visit | ||
| 16.09. | Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment | ||
| 16.09. | Chiesi appoints David Khougazian as Group CEO | ||
| 15.09. | When what matters to patients is hard to measure | ||
| 15.09. | Pessimism, practice and policy: are we still making the right argument for health innovation? | ||
| 15.09. | J&J's Darzalex combination treatment for untreated multiple myeloma recommended by NICE | ||
| 14.09. | AstraZeneca's Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer | ||
| 11.09. | AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer | ||
| 11.09. | Langland appoints Kathryn Stewart as Head of Strategy and promotes Diane Ross to Head of Scientific Practice | ||
| 10.09. | Novo Nordisk UK appoints George Godfrey as Senior Director, Medical & Regulatory | ||
| 10.09. | Roche's Enspryng gets FDA Priority Review for autoimmune disease with no approved treatments | ||
| 09.09. | Gilead opens new research centre bringing together oncology, inflammation and research data science teams |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.